Suppression of tumour metastasis in a murine osteosarcoma model with anti-CD25 monoclonal antibody treatment

Anticancer Research

Volumn 30, Issue 12, 2010, Pages 5019-5022

  Kozawa, Eiji ^a   Sugiura, Hideshi ^b   Wasa, Junshi ^a   Kohyama, Keishi ^b   Yamada, Kenji ^b   Nishioka, Akiko ^c   Nishida, Yoshihiro ^a   Ishiguro, Naoki ^a   Taguchi, Osamu ^b,c  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

^c NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Anti CD25; Osteosarcoma; Regulatory T cell treg

Indexed keywords

BASILIXIMAB; PC61 MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; LIVER METASTASIS; LUNG METASTASIS; MALE; METASTASIS; MOUSE; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; ANTIBODIES, MONOCLONAL; BONE NEOPLASMS; CD4-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED C3H; NEOPLASM TRANSPLANTATION; OSTEOSARCOMA;

EID: 78751525413     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Arndt CA and Crist WM: Common musculoskeletal tumors of childhood and adolescence. N Engl J Med 341: 1702-1703, 1999.
2. Meyers PA, Schwartz CL, Krailo M, Kleinerman ES, Betcher D, Bernstein ML, Conrad E Ferguson W, Gebhardt M, Goorin AM, Harris MB, Healey J, Huvos A, Link M, Montebello J, Nadel H, Nieder M, Sato J, Siegal G, Weiner M, Wells R, Wold L, Womer R and Grier H: Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. J Clin Oncol 23: 2004-2011, 2005.
3. Taguchi O and Takahashi T: Administration of anti-interleukin2 receptor alpha antibody in vivo induces localized autoimmune disease. Eur J Immunol 26: 1608-1612, 1996.
4. + suppressor T-cell: more questions than answers. Nat Res Immunol 2: 389-400, 2002.
5. + regulatory T-cell for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22: 531-562, 2004.
6. Onizuka S, Tawara I, Shimizu J, Sakaguchi S, Fujita T and Nakayama E: Tumor rejection by in vivo administration of antiCD25 (interleukin-2 receptor alpha) monoclonal antibody. Cancer Res 59: 3128-3133, 1999.
7. + T-cell: a common basis between tumor immunity and autoimmunity. J Immunol 163: 5221-5218, 1999.
8. Mori S, Ueda T, Kuratsu S, Hosono N, Izawa K and Uchida A: Suppression of pulmonary metastasis by angiogenesis inhibitor TNP-470 in murine osteosarcoma. Int J Cancer 61: 148-152, 1995.
9. Kojima A and Prehn RT: Genetic susceptibility to postthymectomy autoimmune diseases in mice. Immnogenetics 14: 15-27, 1981. (Pubitemid 12246051)
10. Bluestone JA and Abbas AK: Natural versus adaptive regulatory T-cells. Nat Rev Immunol 5: 253-257, 2003.